Department of Endocrinology, Affiliated Hospital of Jilin Medical University, Jilin, China.
Medicine (Baltimore). 2021 Apr 16;100(15):e25432. doi: 10.1097/MD.0000000000025432.
To analyze the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus (T2DM) complicated with hypothyroidism.Fifty-five patients with type-2 diabetes who were admitted to our hospital from August 2018 to February 2020 were selected as the control group, and 55 patients with type 2 diabetes combined with hypothyroidism who were admitted to the hospital at the same period were selected as the combined group, and 56 patients who came to our hospital for physical examination at the same period were selected as the healthy group. The general clinical data and relevant laboratory indexes of all patients in the three groups were collected and statistically analyzed. Besides, the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and T2DM complicated with hypothyroidism was analyzed.Levels of FPG, FINS, TC, TG, LDL, 2hPBG, TPOAb, TgAb, and HOMA-IR in the diabetes group and combined group were all significantly higher than those in the healthy group, while HDL and T4 levels in the diabetes group and combined group were lower than those in the healthy group (P < .05). The levels of FPG, FINS, TC, TG, LDL, 2hPBG, TPOAb, and TgAb in the combined group were significantly higher than those in the diabetes group (P < .05), and the levels of HDL and T4 were lower than those in the diabetes group. In addition, the IGF-1 level was positively correlated with ZAG, nesfatin-1, and HbA1c levels in the combined group (P < .05), and IGF-1 (OR: 0.964, 95% CI: 0.943-0.983, P = .001), ZAG (OR: 1.298, 95% CI: 1.121-1.401, P = .005), nesfatin-1 (OR: 0.876, 95% CI: 0.751-0.901, P = .002), and HbA1c (OR: 1.321, 95% CI: 1.121-1.401, P = .012) were independent risk factors for T2DM complicated with hypothyroidism.Regular detection of IGF-1, ZAG, nesfatin-1, and HbA1c levels are of great value for the diagnosis and treatment of patients with T2DM complicated with hypothyroidism.
分析 IGF-1、ZAG、nesfatin-1、HbA1c 水平与 2 型糖尿病(T2DM)合并甲状腺功能减退症的相关性。选取 2018 年 8 月至 2020 年 2 月我院收治的 55 例 2 型糖尿病患者为对照组,同期收治的 55 例 2 型糖尿病合并甲状腺功能减退症患者为联合组,同期来我院体检的 56 例患者为健康组。收集三组患者的一般临床资料及相关实验室指标,并进行统计学分析。此外,分析 IGF-1、ZAG、nesfatin-1、HbA1c 水平与 T2DM 合并甲状腺功能减退症的相关性。糖尿病组和联合组的 FPG、FINS、TC、TG、LDL、2hPBG、TPOAb、TgAb 和 HOMA-IR 水平均明显高于健康组,而糖尿病组和联合组的 HDL 和 T4 水平明显低于健康组(P<0.05)。联合组的 FPG、FINS、TC、TG、LDL、2hPBG、TPOAb 和 TgAb 水平明显高于糖尿病组(P<0.05),HDL 和 T4 水平明显低于糖尿病组。此外,联合组 IGF-1 水平与 ZAG、nesfatin-1 和 HbA1c 水平呈正相关(P<0.05),IGF-1(OR:0.964,95%CI:0.943-0.983,P=0.001)、ZAG(OR:1.298,95%CI:1.121-1.401,P=0.005)、nesfatin-1(OR:0.876,95%CI:0.751-0.901,P=0.002)和 HbA1c(OR:1.321,95%CI:1.121-1.401,P=0.012)是 T2DM 合并甲状腺功能减退症的独立危险因素。定期检测 IGF-1、ZAG、nesfatin-1 和 HbA1c 水平对 T2DM 合并甲状腺功能减退症患者的诊断和治疗具有重要价值。